Position in AMGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$131,444,128
-$7,660,121 QoQ
Shares Held
362,985
-8.2% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#119
of 3,151 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Candriam S.C.A. holds $1,583,496,479 across 9 Drug Manufacturers - General names. AMGN ranks #5 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
401,970 | $482,134,917 | |
| 2 | ABBV |
AbbVie Inc.
|
1,164,745 | $293,096,431 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,419,478 | $182,402,923 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,191,380 | $150,518,949 | |
| 5 | AMGN |
Amgen Inc
This page
|
362,985 | $131,444,128 | |
| 6 | JNJ |
Johnson & Johnson
|
510,174 | $129,568,890 | |
| 7 | BIIB |
Biogen Inc.
|
384,326 | $83,037,475 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,196,072 | $68,917,668 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $131,444,128 | 362,985 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $139,104,249 | 395,351 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $128,218,782 | 391,735 | Shares | Sole | 2026-04-30 | |
| 2025-09-30 | $125,641,084 | 445,220 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $141,202,081 | 505,720 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $157,707,544 | 506,203 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $160,951,715 | 617,525 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $261,987,662 | 813,096 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $190,646,991 | 610,168 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $195,714,515 | 688,360 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $218,728,436 | 759,421 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $231,600,435 | 861,737 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $154,330,986 | 695,122 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $243,153,600 | 1,005,806 | Shares | Other | 2023-05-12 | |
| 2022-12-31 | $257,330,994 | 979,786 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $217,719,494 | 965,925 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $227,708,118 | 935,915 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $225,795,313 | 933,733 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $260,315,710 | 1,157,113 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $235,999,820 | 1,109,804 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $234,891,393 | 963,657 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $329,475,445 | 1,324,205 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $304,457,764 | 1,324,190 | Shares | Other | 2021-01-22 | |
| 2020-09-30 | $320,841,163 | 1,262,359 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $205,502,459 | 871,290 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $183,464,162 | 904,968 | Shares | Sole | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||